We report a novel BRCA1 germline 4156delAA mutation detected in a 41-year-old woman with breast and ovarian cancer. Genomic DNA was obtained from peripheral blood. Standard polymerase chain reactions and direct sequencing were performed. This mutation originates a premature stop at codon 1354 of BRCA1 protein and has not been documented in any published report to the best of our knowledge. The mutation was not observed in any other family studied. Since this novel mutation was associated with both breast and ovarian cancer, the genotype-phenotype correlation was investigated in a patient base of 30 families
Session - Tumor Biology and Human GeneticsBACKGROUND: Germline mutations in BRCA1/2 account for a si...
Hereditary breast and ovarian cancer is caused by a germline mutation in BRCA1 or BRCA2 genes. The f...
SummaryFor genetic counseling and predictive testing in families with inherited breast-ovarian cance...
Germline mutations in the human breast cancer genes BRCA1 and BRCA2 account for a substantial propor...
A population-based series of 649 unselected incident cases of ovarian cancer diagnosed in Ontario, C...
Nowadays, genetic analysis of hereditary breast/ovarian cancer plays an important role in understand...
Germline mutations in BRCA1 gene account for varying proportions of breast/ovarian cancer families, ...
A group of 103 sicilian patients with hereditary and familiar breast and/or ovarian cancer were scre...
Germline mutations in the BRCA1 and BRCA2 genes predispose women to breast and ovarian cancer. An in...
In order to adequately evaluate the clinical relevance of genetic testing in sporadic breast and ova...
Breast and ovarian cancers account for approximately 210000 newly diagnosed cases per year. More tha...
The importance of proper mutational analysis of BRCA1/2 in individuals at risk for hereditary breast...
Background: Mutations in the high penetrance breast and ovarian cancer susceptibility gene BRCA1 acc...
Breast cancer is the most common malignancy in women. Most of the breast cancers are sporadic with n...
A total of 845 women from breast-ovarian cancer kindreds were enrolled in a clinical follow-up progr...
Session - Tumor Biology and Human GeneticsBACKGROUND: Germline mutations in BRCA1/2 account for a si...
Hereditary breast and ovarian cancer is caused by a germline mutation in BRCA1 or BRCA2 genes. The f...
SummaryFor genetic counseling and predictive testing in families with inherited breast-ovarian cance...
Germline mutations in the human breast cancer genes BRCA1 and BRCA2 account for a substantial propor...
A population-based series of 649 unselected incident cases of ovarian cancer diagnosed in Ontario, C...
Nowadays, genetic analysis of hereditary breast/ovarian cancer plays an important role in understand...
Germline mutations in BRCA1 gene account for varying proportions of breast/ovarian cancer families, ...
A group of 103 sicilian patients with hereditary and familiar breast and/or ovarian cancer were scre...
Germline mutations in the BRCA1 and BRCA2 genes predispose women to breast and ovarian cancer. An in...
In order to adequately evaluate the clinical relevance of genetic testing in sporadic breast and ova...
Breast and ovarian cancers account for approximately 210000 newly diagnosed cases per year. More tha...
The importance of proper mutational analysis of BRCA1/2 in individuals at risk for hereditary breast...
Background: Mutations in the high penetrance breast and ovarian cancer susceptibility gene BRCA1 acc...
Breast cancer is the most common malignancy in women. Most of the breast cancers are sporadic with n...
A total of 845 women from breast-ovarian cancer kindreds were enrolled in a clinical follow-up progr...
Session - Tumor Biology and Human GeneticsBACKGROUND: Germline mutations in BRCA1/2 account for a si...
Hereditary breast and ovarian cancer is caused by a germline mutation in BRCA1 or BRCA2 genes. The f...
SummaryFor genetic counseling and predictive testing in families with inherited breast-ovarian cance...